The Cooper Companies found using ticker (COO) now have 12 analysts in total covering the stock. The consensus rating is ‘Buy’. The range between the high target price and low target price is between 560 and 385 calculating the mean target price we have 475.25. Given that the stocks previous close was at 424.54 this is indicating there is a potential upside of 11.9%. The 50 day moving average now sits at 403.97 while the 200 day moving average is 409.32. The market capitalisation for the company is $19,780m. Find out more information at: https://www.coopercos.com
The potential market cap would be $22,143m based on the market concensus.
The Cooper Companies, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lenseluding lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women’s health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office productsluding PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies was founded in 1958 and is headquartered in San Ramon, California.
